Table 3

SNP variants associated with stroke/TIA

SNPDiscovery cohort
(Sweden)*
Replication cohort
(UCSF)†
Meta-analysis
LocusM/mMAFOR (95% CI)P valuesMAFOR (95% CI)P valuesOR (95% CI)P values
rs799454SRP54-AS1A/G0.57/0.401.8 (1.3 to 2.4)2.2×10−4 0.50/0.401.6 (1.03 to 2.3)3.4×10−2 1.7 (1.3 to 2.2)2.5×10−5
rs1712349SRP54-AS1C/T0.56/0.401.8 (1.3 to 2.4)2.2×10−4 0.50/0.401.6 (1.03 to 2.3)3.6×10−2 1.7 (1.3 to 2.2)2.5×10−5
rs712308SRP54-AS1C/T0.56/0.401.8 (1.3 to 2.4)2.2×10−4 0.50/0.401.5 (1.02 to 2.3)4.2×10−2 1.7 (1.3 to 2.2)3.0×10−5
rs11567698IL7RG/T0.18/0.111.8 (1.2 to 2.8)3.4×10−3 0.18/0.101.9 (1.1 to 3.1)1.6×10−2 1.9 (1.3 to 2.5)1.5×10−4
rs11567714IL7RC/T0.18/0.111.8 (1.2 to 2.8)3.4×10−3 0.17/0.101.9 (1.1 to 3.4)3.3×10−2 1.9 (1.3 to 2.6)2.8×10−4
  • The five SNPs showing an association with stroke and/or TIA in both cohorts.

  • *96 patients with and 718 without stroke/TIA.

  • †55 patients with and 988 without stroke; no data regarding TIA in the replication cohort.

  • SNPs with P<0.001 in the meta-analysis were forwarded for functional analyses.

  • M/m, major/minor alleles; MAF, minor allele frequency for  cases / controls ; P, P value unadjusted; SNP, single nucleotide polymorphisms; TIA, transient  ischaemic attack; UCSF, University of California, San Fransisco.